(Q33330239)

25 July 2017

title

Platelet count and function in children receiving sodium valproate (English)

1 reference

25 July 2017

Verrotti A

1

1 reference

25 July 2017

Greco R

2

1 reference

25 July 2017

Matera V

3

1 reference

25 July 2017

Altobelli E

4

1 reference

25 July 2017

Morgese G

5

1 reference

25 July 2017

Chiarelli F

6

1 reference

25 July 2017

publication date

1 September 1999

1 reference

25 July 2017

1 reference

25 July 2017

volume

21

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

611-614

1 reference

Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Pharmacology of valproic acid in children with severe epilepsy: clearance and hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Valproic acid versus ethosuximide in the treatment of absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Drug therapy: Valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Valproic acid therapy in childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Adverse effects of valproate.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Sodium valproate, platelet dysfunction, and bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Interaction between sodium valproate and platelets: a further study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Letter: Sodium valproate and platelet function.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Capillary gas chromatographic assay for valproic acid and its 2-desaturated metabolite in brain and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Valproic acid and immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Sodium valproate: monotherapy and polytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Thrombocytopenia associated with sodium valproate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

The platelet aggregation in children with epilepsy receiving valproic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Thrombocytopenia secondary to high valproate levels in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Sodium valproate and platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Thrombocytopenia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

Intraoperative defect in haemostasis in a child receiving valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900060-0

7 January 2021

10.1016/S0887-8994(99)00060-0

Identifiers

DOI

1 reference

25 July 2017

1 reference